These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 1890413)

  • 1. Autoantibodies during alpha-interferon therapy for chronic hepatitis B.
    Fattovich G; Betterle C; Brollo L; Pedini B; Giustina G; Realdi G; Alberti A; Ruol A
    J Med Virol; 1991 Jun; 34(2):132-5. PubMed ID: 1890413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of chronic type B hepatitis with recombinant alpha-interferon induces autoantibodies not specific for autoimmune chronic hepatitis.
    Mayet WJ; Hess G; Gerken G; Rossol S; Voth R; Manns M; Meyer zum Büschenfelde KH
    Hepatology; 1989 Jul; 10(1):24-8. PubMed ID: 2737600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmunity against pancreatic islets and other tissues before and after interferon-alpha therapy in patients with hepatitis C virus chronic infection.
    Betterle C; Fabris P; Zanchetta R; Pedini B; Tositti G; Bosi E; de Lalla F
    Diabetes Care; 2000 Aug; 23(8):1177-81. PubMed ID: 10937518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-alpha therapy may induce insulin autoantibody development in patients with chronic viral hepatitis.
    di Cesare E; Previti M; Russo F; Brancatelli S; Ingemi MC; Scoglio R; Mazzù N; Cucinotta D; Raimondo G
    Dig Dis Sci; 1996 Aug; 41(8):1672-7. PubMed ID: 8769300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibody prevalence in chronic hepatitis B virus infection: effect in interferon alfa.
    Gregorio GV; Jones H; Choudhuri K; Vegnente A; Bortolotti F; Mieli-Vergani G; Vergani D
    Hepatology; 1996 Sep; 24(3):520-3. PubMed ID: 8781317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of autoantibodies during alpha interferon treatment in chronic hepatitis B.
    Fattovich G; Betterle C; Brollo L; Giustina G; Pedini B; Alberti A
    Arch Virol Suppl; 1992; 4():291-3. PubMed ID: 1450705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune endocrine disease induced by recombinant interferon-alpha therapy for chronic active type C hepatitis.
    Imagawa A; Itoh N; Hanafusa T; Oda Y; Waguri M; Miyagawa J; Kono N; Kuwajima M; Matsuzawa Y
    J Clin Endocrinol Metab; 1995 Mar; 80(3):922-6. PubMed ID: 7883851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a.
    Preziati D; La Rosa L; Covini G; Marcelli R; Rescalli S; Persani L; Del Ninno E; Meroni PL; Colombo M; Beck-Peccoz P
    Eur J Endocrinol; 1995 May; 132(5):587-93. PubMed ID: 7749499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant interferon-alpha 2a hastens the rate of HBeAg clearance in children with chronic hepatitis B.
    Barbera C; Bortolotti F; Crivellaro C; Coscia A; Zancan L; Cadrobbi P; Nebbia G; Pillan MN; Lepore L; Parrella T
    Hepatology; 1994 Aug; 20(2):287-90. PubMed ID: 8045488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of thyroid autoimmunity after administration of recombinant human interferon-alpha 2b for chronic viral hepatitis.
    Chung YH; Shong YK
    Am J Gastroenterol; 1993 Feb; 88(2):244-7. PubMed ID: 8424429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological markers of autoimmunity in renal transplant patients before and after alpha-interferon therapy for chronic hepatitis C.
    Rostaing L; Oksman F; Izopet J; Baron E; Cisterne JM; Hoff M; Abbal M; Durand D
    Am J Nephrol; 1996; 16(6):478-83. PubMed ID: 8955758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effect of low dose recombinant interferon therapy in patients with chronic hepatitis B.
    Fattovich G; Brollo L; Boscaro S; Pontisso P; Giustina G; Criscuolo D; Maladorno D; Alberti A; Realdi G; Ruol A
    J Hepatol; 1989 Nov; 9(3):331-7. PubMed ID: 2691568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B.
    Niederau C; Heintges T; Niederau M; Stremmel W; Strohmeyer G
    Eur J Med; 1992 Nov; 1(7):396-402. PubMed ID: 1341478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of chronic anti-HBe-positive hepatitis B with interferon-alpha.
    Brunetto MR; Oliveri F; Colombatto P; Capalbo M; Barbera C; Bonino F
    J Hepatol; 1995; 22(1 Suppl):42-4. PubMed ID: 7602075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies in children with chronic hepatitis B infection and the influence of interferon alpha.
    Kansu A; Kuloğlu Z; Demirçeken F; Girgin N
    Turk J Gastroenterol; 2004 Dec; 15(4):213-8. PubMed ID: 16249973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Investigation of autoimmunity markers during interferon alpha therapy of chronic hepatitis B and C - twenty years of experience].
    Orságová I; RoŽnovský L; Petroušová L; Konečná M; Kabieszová L; Martinek J; Kloudová A; Pavliska L
    Klin Mikrobiol Infekc Lek; 2016 Jun; 22(2):61-7. PubMed ID: 27450524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment effect of alpha interferon in chronic hepatitis B is independent of pre-treatment variables. Results based on individual patient data from 10 clinical controlled trials. European Concerted Action on Viral Hepatitis (Eurohep).
    Krogsgaard K; Bindslev N; Christensen E; Craxi A; Schlichting P; Schalm S; Carreno V; Trepo C; Gerken G; Thomas HC
    J Hepatol; 1994 Oct; 21(4):646-55. PubMed ID: 7814812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled trial of thymosin-alpha1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody--and hepatitis B virus DNA--positive chronic hepatitis B.
    Andreone P; Cursaro C; Gramenzi A; Zavagliz C; Rezakovic I; Altomare E; Severini R; Franzone JS; Albano O; Ideo G; Bernardi M; Gasbarrini G
    Hepatology; 1996 Oct; 24(4):774-7. PubMed ID: 8855175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies before, during and after administration of recombinant interferon-alpha for chronic viral hepatitis.
    Lopes EP; Silva AE; Sette Junior H; Guimarães RX; Ferraz ML
    Rev Inst Med Trop Sao Paulo; 1995; 37(5):455-60. PubMed ID: 8729757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.